Sotalol HCl 15mg/mL; soln for IV infusion after dilution. Sotalol has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams ...
Atrial fibrillation is common, affecting approximately 5.2 million patients in 2010 in the United States, and this is projected to increase to 12.1 million in 2030. Tanvi Patil Stacey Zysk Kezia ...
Sotalol is a class III antiarrhythmic drug and acts by blocking cardiac potassium channels. Sotalol also has nonselective beta-blocker properties. Sotalol exhibits “reverse use-dependence,” meaning at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results